title: Primary glaucoma triple procedure with or without adjunctive mitomycin. Prognostic factors for filtration failure.
abstract: OBJECTIVE
  The prerequisite for selective use of adjunctive mitomycin C (MMC) in primary glaucoma triple procedure (PGTP) is a better understanding of the prognostic factors. Therefore, the authors carried out the current study on the outcome of PGTP with and without adjunctive MMC to determine the prognostic factors for filtration failure of PGTP.
  
  
  METHODS
  The study patients consisted of 174 consecutive primary open-angle glaucoma (POAG) patients undergoing PGTP. They were assigned randomly to either no adjunctive MMC (93 eyes of 93 patients) or adjunctive subconjunctival MMC (81 eyes of 81 patients) during the PGTP. After surgery, the patients were examined at regular intervals for visual acuity, intraocular pressure (IOP) control, medical therapy requirements, and complications. Filtration failure was determined according to two different criteria: (1) a less stringent set of criteria (criterion I) and (2) a more stringent set of criteria (criterion II).
  
  
  RESULTS
  There were no statistically significant differences between the groups with and without adjunctive MMC with respect to postoperative IOP, number of medications, and visual acuity outcome during mean follow-up (+/- standard deviation) of 25.1 +/- 5.5 months (P > 0.05 for each). However, there were prognostic factors for filtration failure in the control group but not in the MMC group. Black race, diabetes mellitus, preoperative IOP greater than or equal to 20 mmHg, and number of preoperative medications greater than two were found to be significant prognostic factors for filtration failure by criterion I. Black race, preoperative IOP greater than or equal to 20 mmHg and number of preoperative medications greater than 1 were significant prognostic factors for filtration failure by criterion II.
  
  
  CONCLUSIONS
  There was no statistically significant difference in the overall outcome of PGTP between control and MMC groups of nonselected patients with primary open-angle glaucoma. Black race, diabetes mellitus (by criterion I only), preoperative IOP greater than or equal to 20 mmHg, and number of preoperative medications greater than 2 (by criterion I) or greater than 1 (by criterion II) were found to be significant independent prognostic factors for filtration failure of PGTP without adjunctive MMC but no with adjunctive MMC. The use of adjunctive subconjunctival MMC in PGTP may have to be selective, primarily in those patients with primary open-angle glaucoma with one or more of the prognostic factors for filtration failure.
authors.affiliation: Kresge Eye Institute, Wayne State University School of Medicine, Detroit 48201-1423, USA.
authors.forename: D H
authors.initials: DH
authors.lastname: Shin
authors.forename: B A
authors.initials: BA
authors.lastname: Hughes
authors.forename: M S
authors.initials: MS
authors.lastname: Song
authors.forename: C
authors.initials: C
authors.lastname: Kim
authors.forename: K J
authors.initials: KJ
authors.lastname: Yang
authors.forename: M I
authors.initials: MI
authors.lastname: Shah
authors.forename: M S
authors.initials: MS
authors.lastname: Juzych
authors.forename: T
authors.initials: T
authors.lastname: Obertynski
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D002387:Cataract Extraction; D017024:Chemotherapy, Adjuvant; D005260:Female; D005902:Glaucoma, Open-Angle / Q000188:drug therapy / Q000601:surgery*; D006801:Humans; D007429:Intraocular Pressure; D007910:Lenses, Intraocular; D008297:Male; D008875:Middle Aged; D016685:Mitomycin / Q000627:therapeutic use*; D019384:Nucleic Acid Synthesis Inhibitors / Q000627:therapeutic use*; D011183:Postoperative Complications; D011379:Prognosis; D012307:Risk Factors; D014130:Trabeculectomy; D017211:Treatment Failure; D014792:Visual Acuity
chemical_list: D019384:Nucleic Acid Synthesis Inhibitors; D016685:Mitomycin